BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maski K, Steinhart E, Williams D, Scammell T, Flygare J, McCleary K, Gow M. Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy. J Clin Sleep Med 2017;13:419-25. [PMID: 27923434 DOI: 10.5664/jcsm.6494] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Giannoccaro MP, Sallemi G, Liguori R, Plazzi G, Pizza F. Immunotherapy in Narcolepsy. Curr Treat Options Neurol 2020;22:2. [PMID: 31997035 DOI: 10.1007/s11940-020-0609-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Postiglione E, Pizza F, Ingravallo F, Vignatelli L, Filardi M, Mangiaruga A, Antelmi E, Moresco M, Oriolo C, Pagotto U, Plazzi G. Impact of COVID-19 pandemic lockdown on narcolepsy type 1 management. Brain Behav 2021;11:e01955. [PMID: 33247632 DOI: 10.1002/brb3.1955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Lecendreux M, Plazzi G, Franco P, Jacqz-aigrain E, Robert P, Duvauchelle T, Schwartz J. Pharmacokinetics of pitolisant in children and adolescents with narcolepsy. Sleep Medicine 2020;66:220-6. [DOI: 10.1016/j.sleep.2019.10.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
4 Ballotta D, Talami F, Pizza F, Vaudano AE, Benuzzi F, Plazzi G, Meletti S. Hypothalamus and amygdala functional connectivity at rest in narcolepsy type 1. Neuroimage Clin 2021;31:102748. [PMID: 34252875 DOI: 10.1016/j.nicl.2021.102748] [Reference Citation Analysis]
5 Zhang Z, Dauvilliers Y, Plazzi G, Mayer G, Lammers GJ, Santamaria J, Partinen M, Overeem S, Del Rio Villegas R, Sonka K, Peraita-Adrados R, Heinzer R, Wierzbicka A, Högl B, Manconi M, Feketeova E, da Silva AM, Bušková J, Bassetti CLA, Barateau L, Pizza F, Antelmi E, Gool JK, Fronczek R, Gaig C, Khatami R. Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy Diagnosis. Nat Sci Sleep 2022;14:1031-47. [PMID: 35669411 DOI: 10.2147/NSS.S359980] [Reference Citation Analysis]
6 Setnik B, McDonnell M, Mills C, Scart-Grès C, Robert P, Dayno JM, Schwartz JC. Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy. Sleep 2020;43:zsz252. [PMID: 31626696 DOI: 10.1093/sleep/zsz252] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
7 Chen TY, Huang CH, Chung CH, Mao WC, Yeh CB, Yang CCH, Kuo TBJ, Yang SS, Chien WC, Tzeng NS. Sex and age differences in the association between anxiety disorders and narcolepsy: A nationwide population-based case control study. J Affect Disord 2020;264:130-7. [PMID: 32056742 DOI: 10.1016/j.jad.2019.12.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
8 Graef DM, Byars KC, Simakajornboon N, Dye TJ. Topical Review: A Biopsychosocial Framework for Pediatric Narcolepsy and Idiopathic Hypersomnia. J Pediatr Psychol 2020;45:34-9. [PMID: 31670813 DOI: 10.1093/jpepsy/jsz085] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Davis CW, Kallweit U, Schwartz JC, Krahn LE, Vaughn B, Thorpy MJ. Efficacy of pitolisant in patients with high burden of narcolepsy symptoms: pooled analysis of short-term, placebo-controlled studies. Sleep Med 2021;81:210-7. [PMID: 33721598 DOI: 10.1016/j.sleep.2021.02.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Pellitteri G, de Biase S, Valente M, Gigli GL. How treatable is narcolepsy with current pharmacotherapy and what does the future hold? Expert Opin Pharmacother 2021;22:1517-20. [PMID: 33882765 DOI: 10.1080/14656566.2021.1915987] [Reference Citation Analysis]
11 Bassetti CLA, Adamantidis A, Burdakov D, Han F, Gay S, Kallweit U, Khatami R, Koning F, Kornum BR, Lammers GJ, Liblau RS, Luppi PH, Mayer G, Pollmächer T, Sakurai T, Sallusto F, Scammell TE, Tafti M, Dauvilliers Y. Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 2019;15:519-39. [DOI: 10.1038/s41582-019-0226-9] [Cited by in Crossref: 113] [Cited by in F6Publishing: 89] [Article Influence: 37.7] [Reference Citation Analysis]
12 Morris S, Plazzi G, Loge CDL, Marrel A, Profant J, Steininger TL, Lin J, Owens JA. Validation of the Pediatric Narcolepsy Screening Questionnaire (PNSQ):A cross-sectional, observational study. Sleep Medicine 2022. [DOI: 10.1016/j.sleep.2022.05.017] [Reference Citation Analysis]
13 Silvani A, Vandi S, Pizza F, Antelmi E, Ferri R, Plazzi G. Combining information on nocturnal rapid eye movement sleep latency and atonia to facilitate diagnosis of pediatric narcolepsy type 1. Sleep 2021;44:zsaa203. [PMID: 33035342 DOI: 10.1093/sleep/zsaa203] [Reference Citation Analysis]
14 Zomorodi K, Kankam M, Lu Y. A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food. Clinical Therapeutics 2019;41:196-204. [DOI: 10.1016/j.clinthera.2018.12.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
15 Thorpy MJ, Ohayon MM, Carls G, Black J, Pasta DJ, Hyman DL, Villa KF. Assessing the impact of sodium oxybate treatment on functioning, productivity, and health-related quality of life in patients with narcolepsy: findings from the Nexus Narcolepsy Registry (waves 1-4). Sleep Med 2021;84:380-8. [PMID: 34247126 DOI: 10.1016/j.sleep.2021.06.010] [Reference Citation Analysis]
16 Plazzi G, Clawges HM, Owens JA. Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy. Pediatric Neurology 2018;85:21-32. [DOI: 10.1016/j.pediatrneurol.2018.06.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
17 Yang J, Gao J. Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy. Expert Review of Clinical Pharmacology 2019;12:723-8. [DOI: 10.1080/17512433.2019.1632705] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Edwards K, Lambert PH, Black S. Narcolepsy and Pandemic Influenza Vaccination: What We Need to Know to be Ready for the Next Pandemic. Pediatr Infect Dis J 2019;38:873-6. [PMID: 31306400 DOI: 10.1097/INF.0000000000002398] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
19 Ong JC, Fox RS, Brower RF, Mazurek S, Moore C. How Does Narcolepsy Impact Health-Related Quality of Life? A Mixed-Methods Study. Behav Sleep Med 2021;19:145-58. [PMID: 31937147 DOI: 10.1080/15402002.2020.1715411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Maski K, Pizza F, Liu S, Steinhart E, Little E, Colclasure A, Diniz Behn C, Vandi S, Antelmi E, Weller E, Scammell TE, Plazzi G. Defining disrupted nighttime sleep and assessing its diagnostic utility for pediatric narcolepsy type 1. Sleep 2020;43:zsaa066. [PMID: 32253429 DOI: 10.1093/sleep/zsaa066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
21 Ohayon MM, Thorpy MJ, Carls G, Black J, Cisternas M, Pasta DJ, Bujanover S, Hyman D, Villa KF. The Nexus Narcolepsy Registry: methodology, study population characteristics, and patterns and predictors of narcolepsy diagnosis. Sleep Med 2021;84:405-14. [PMID: 34304148 DOI: 10.1016/j.sleep.2021.06.008] [Reference Citation Analysis]
22 Worhach J, Boduch M, Zhang B, Maski K. Remote Assessment of Cognition in Kids and Adolescents with Daytime Sleepiness: A pilot study of feasibility and reliability. medRxiv 2021:2021. [PMID: 33791741 DOI: 10.1101/2021.03.24.21254190] [Reference Citation Analysis]
23 Krahn LE, Zee PC, Thorpy MJ. Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know. Adv Ther 2022;39:221-43. [PMID: 34894325 DOI: 10.1007/s12325-021-01992-4] [Reference Citation Analysis]
24 Pérez-carbonell L, Lyons E, Gnoni V, Higgins S, Otaiku AI, Leschziner GD, Drakatos P, d’Ancona G, Kent BD. Adherence to wakefulness promoting medication in patients with narcolepsy. Sleep Medicine 2020;70:50-4. [DOI: 10.1016/j.sleep.2020.02.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Li C, Xie L, Shang S, Dong X, Wang X, Zhao L, Zhang C, Han F. Narcolepsy Quality-of-Life Instrument with 21 Questions: A Translation and Validation Study in Chinese Pediatric Narcoleptics. Nat Sci Sleep 2021;13:1701-10. [PMID: 34675719 DOI: 10.2147/NSS.S322796] [Reference Citation Analysis]
26 Parmar A, Murray BJ, Narang I. Clinical Characteristics of Cataplectic Attacks in Type 1 Narcolepsy. Curr Neurol Neurosci Rep 2020;20:38. [PMID: 32651734 DOI: 10.1007/s11910-020-01057-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Antelmi E, Pizza F, Vandi S, Plazzi G. Stereotyped episodes of aphasia and immobility: how cataplexy mimics stroke in an elderly patient. Sleep Med 2017;36:122-4. [PMID: 28735909 DOI: 10.1016/j.sleep.2017.05.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
28 Pizza F, Filardi M, Moresco M, Antelmi E, Vandi S, Neccia G, Mazzoni A, Plazzi G. Excessive daytime sleepiness in narcolepsy and central nervous system hypersomnias. Sleep Breath 2020;24:605-14. [DOI: 10.1007/s11325-019-01867-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
29 Franceschini C, Pizza F, Cavalli F, Plazzi G. A practical guide to the pharmacological and behavioral therapy of Narcolepsy. Neurotherapeutics 2021;18:6-19. [PMID: 33886090 DOI: 10.1007/s13311-021-01051-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Vignatelli L, Antelmi E, Ceretelli I, Bellini M, Carta C, Cortelli P, Ferini-Strambi L, Ferri R, Guerrini R, Ingravallo F, Marchiani V, Mari F, Pieroni G, Pizza F, Verga MC, Verrillo E, Taruscio D, Plazzi G. Red Flags for early referral of people with symptoms suggestive of narcolepsy: a report from a national multidisciplinary panel. Neurol Sci 2019;40:447-56. [PMID: 30539345 DOI: 10.1007/s10072-018-3666-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
31 Meskill GJ, Kallweit U, Zarycranski D, Caussé C, Finance O, Ligneau X, Davis CW. Pitolisant for the treatment of cataplexy in adults with narcolepsy. Expert Opinion on Orphan Drugs. [DOI: 10.1080/21678707.2021.2022472] [Reference Citation Analysis]
32 Quaedackers L, Pillen S, Overeem S. Recognizing the Symptom Spectrum of Narcolepsy to Improve Timely Diagnosis: A Narrative Review. Nat Sci Sleep 2021;13:1083-96. [PMID: 34262379 DOI: 10.2147/NSS.S278046] [Reference Citation Analysis]
33 Coffey AA, Joyal AA, Yamanaka A, Scammell TE. The Impacts of Age and Sex in a Mouse Model of Childhood Narcolepsy. Front Neurosci 2021;15:644757. [PMID: 33746708 DOI: 10.3389/fnins.2021.644757] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Morse AM, Sanjeev K. Narcolepsy and Psychiatric Disorders: Comorbidities or Shared Pathophysiology? Med Sci (Basel) 2018;6:E16. [PMID: 29462876 DOI: 10.3390/medsci6010016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
35 Maski KP, Colclasure A, Little E, Steinhart E, Scammell TE, Navidi W, Diniz Behn C. Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence. Sleep 2021;44:zsab021. [PMID: 33512510 DOI: 10.1093/sleep/zsab021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Barker EC, Flygare J, Paruthi S, Sharkey KM. Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns. Nat Sci Sleep 2020;12:453-66. [PMID: 32765142 DOI: 10.2147/NSS.S162762] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Maski K, Trotti LM, Kotagal S, Robert Auger R, Swick TJ, Rowley JA, Hashmi SD, Watson NF. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2021;17:1895-945. [PMID: 34743790 DOI: 10.5664/jcsm.9326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
38 Thorpy MJ, Shapiro C, Mayer G, Corser BC, Emsellem H, Plazzi G, Chen D, Carter LP, Wang H, Lu Y, Black J, Dauvilliers Y. A randomized study of solriamfetol for excessive sleepiness in narcolepsy. Ann Neurol 2019;85:359-70. [PMID: 30694576 DOI: 10.1002/ana.25423] [Cited by in Crossref: 69] [Cited by in F6Publishing: 44] [Article Influence: 34.5] [Reference Citation Analysis]
39 Bin-Hasan S, Videnovic A, Maski K. Nocturnal REM Sleep Without Atonia Is a Diagnostic Biomarker of Pediatric Narcolepsy. J Clin Sleep Med 2018;14:245-52. [PMID: 29351827 DOI: 10.5664/jcsm.6944] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
40 August J, Maski K. Updates on Pediatric Sleep Disorders. Curr Sleep Medicine Rep 2020;6:163-75. [DOI: 10.1007/s40675-020-00184-w] [Reference Citation Analysis]
41 Carls G, Reddy SR, Broder MS, Tieu R, Villa KF, Profant J, Halbower AC. Burden of disease in pediatric narcolepsy: a claims-based analysis of health care utilization, costs, and comorbidities. Sleep Medicine 2020;66:110-8. [DOI: 10.1016/j.sleep.2019.08.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
42 Thorpy MJ, Bogan RK. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications. Sleep Med 2020;68:97-109. [PMID: 32032921 DOI: 10.1016/j.sleep.2019.09.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
43 Quaedackers L, De Wit J, Pillen S, Van Gilst M, Batalas N, Lammers GJ, Markopoulos P, Overeem S. A Mobile App for Longterm Monitoring of Narcolepsy Symptoms: Design, Development, and Evaluation. JMIR Mhealth Uhealth 2020;8:e14939. [PMID: 31909723 DOI: 10.2196/14939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
44 Munkhjargal O, Oka Y, Tanno S, Shimizu H, Fujino Y, Kira T, Ooe A, Eguchi M, Higaki T. Discrepancy between subjective and objective sleepiness in adolescents. Sleep Medicine 2022. [DOI: 10.1016/j.sleep.2022.04.025] [Reference Citation Analysis]
45 Giannoccaro MP, Liguori R, Plazzi G, Pizza F. Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder. Nat Sci Sleep 2021;13:557-77. [PMID: 34007229 DOI: 10.2147/NSS.S275931] [Reference Citation Analysis]
46 Trosman I, Ivanenko A. Classification and Epidemiology of Sleep Disorders in Children and Adolescents. Child Adolesc Psychiatr Clin N Am 2021;30:47-64. [PMID: 33223068 DOI: 10.1016/j.chc.2020.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Schokman A, Glozier N, Aji M, Sun Bin Y, Kairaitis K, Cheung JMY. How patient centric is health policy development? The case of the Parliamentary Inquiry into Sleep Health Awareness in Australia. Aust Health Rev 2022;46:233-43. [PMID: 35380105 DOI: 10.1071/AH21156] [Reference Citation Analysis]
48 Szabo ST, Thorpy MJ, Mayer G, Peever JH, Kilduff TS. Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy. Sleep Med Rev 2019;43:23-36. [PMID: 30503715 DOI: 10.1016/j.smrv.2018.09.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]